Apellis shares surge over 142% in pre-market trading, Biogen to acquire pharmaceutical company Apellis for $5.6 billion
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The company will acquire Apellis at a price of $41 per share, more than double Apellis's closing price on Monday. Through this deal, Biogen will gain ownership of two approved drugs.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Commerzbank: The progress of the Iran war remains crucial for the euro’s outlook
老虎证券•2026/05/22 14:25
Traders have fully priced in a 25 basis point rate hike by the end of 2026 by the Federal Reserve.
BlockBeats•2026/05/22 14:15
State Street increases bitcoin holdings by 145 millions USD
AiCoin•2026/05/22 14:10
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$75,778.64
-2.40%
Ethereum
ETH
$2,072.9
-3.17%
Tether USDt
USDT
$0.9988
-0.02%
BNB
BNB
$652.79
-0.66%
XRP
XRP
$1.34
-2.92%
USDC
USDC
$0.9997
-0.00%
Solana
SOL
$84.77
-3.41%
TRON
TRX
$0.3623
-0.45%
Dogecoin
DOGE
$0.1037
-1.91%
Hyperliquid
HYPE
$55.85
-3.56%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now